Total marrow lymphoid irradiation and cyclophosphamide is associated with low toxicity and good outcomes in patients undergoing hematopoietic stem cell transplantation for acute lymphoblastic leukemia and chronic myeloid leukemia in lymphoid blast crises - A phase I study.

Biju George,Rajesh Balakrishnan,Patricia S,Sharon Lionel,Sushil Selvarajan,Anup J Devasia,Anu Korula,Kavitha M Lakshmi,Fouzia N Aboobacker,Uday Kulkarni,Henry Finlay Godson,Jose Solomon Raj,Aby Abraham,Selvamani Backianathan,Vikram Mathews

Clinical transplantation（2023）

引用 0|浏览9

暂无评分

摘要

The combination of TMLI and cyclophosphamide for myeloablative conditioning is associated with low toxicity and favorable early outcomes in patients undergoing HSCT for ALL and CML-LBC.

查看译文

关键词

cyclophosphamide, HSCT, outcomes, phase I study, TMLI, toxicity

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要